AstraZeneca, Bristol partner with Evinova to use AI in drug development
Source: SeekingAlpha
2026-02-18 10:30:44 ET
More on AstraZeneca, Bristol Myers Squibb
- Bristol-Myers: Walking Blindfolded To A $30 Billion Patent Cliff
- AstraZeneca: Q4 Earnings Analysis - Ticks The Boxes, Upgrading To Buy
- AstraZeneca PLC (AZN) Q4 2025 Earnings Call Transcript
- Bristol Myers wins FDA priority review for multiple myeloma therapy
- RFK Jr. HHS shakeup continues as deputy secretary leaving post - report
Read the full article on Seeking Alpha
For further details see:
AstraZeneca, Bristol partner with Evinova to use AI in drug development
Astellas Pharma Inc
NASDAQ: ALPMF
ALPMF Trading
-13.02% G/L:
$13.83 Last:
646 Volume:
$13.55 Open:
ALPMF Latest News
ALPMF Stock Data
$28,999,226,915
1,808,873,137
N/A
N/A
Pharmaceuticals
Healthcare
JP
Chuo-Ku
